FdaApplication
ANDA 217265
Identifiers
- fda_app_no: ANDA217265
Properties
| Property | Value |
|---|---|
| applicant_name | QILU PHARMACEUTICAL CO LTD |
| application_type | ANDA |
| approval_date | 2024-02-22 |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LENALIDOMIDE | LENALIDOMIDE | 5MG | CAPSULE;ORAL |
| LENALIDOMIDE | LENALIDOMIDE | 25MG | CAPSULE;ORAL |
| LENALIDOMIDE | LENALIDOMIDE | 10MG | CAPSULE;ORAL |
| LENALIDOMIDE | LENALIDOMIDE | 20MG | CAPSULE;ORAL |
| LENALIDOMIDE | LENALIDOMIDE | 2.5MG | CAPSULE;ORAL |
| LENALIDOMIDE | LENALIDOMIDE | 15MG | CAPSULE;ORAL |
6 products